[1]
|
E. C. Gotschlich, I. Goldschneider and M. S. Artenstein, “Human Immunity to the Meningococcus V. The Effect of Immunization with Meningococcal Group C Polysaccharide on the Carrier State,” The Journal of Experimental Medicine, Vol. 129, No. 6, 1969, pp. 1385-1395.
doi:10.1084/jem.129.6.1385
|
[2]
|
H. Keyserling, T. Papa, K. Koranyi, R. Ryall, E. Bassily, M. J. Bybel, K. Sullivan, G. Gilmet and A. Reinhardt, “Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents,” Archives Pediatrics and Adolescent Medicine, Vol. 159, No. 10, 2005, pp. 907-913. doi:10.1001/archpedi.159.10.907
|
[3]
|
S. E. Maslanka, L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai and G. M. Carlone, “Standardization and a Multi-laboratory Comparison of Neisseria meningitidis Serogroup A and C Serum Bactericidal Assays. The Multi-laboratory Study Group,” Clinical and Diagnostic Laboratory Immunology, Vol. 4, No. 2, 1997, pp. 156-167.
|
[4]
|
X. Liu, S. Wang, L. Sendi and M. J. Caulfield, “High-Throughput Imaging of Bacterial Colonies Grown on Filter Plates with Application to Serum Bactericidal Assays,” Journal of Immunological Methods, Vol. 292, No. 1-2, 2004, pp. 187-193. doi:10.1016/j.jim.2004.06.021
|
[5]
|
L. E. Little, “Validation of Immunological and Biological Methods,” Biopharm-the Technology & Business of Bi pharmaceuticals, Vol. 8, No. 9, 1995, pp. 36-42.
|